SILEXION THERAPEUTICS CORP Employee-related Liabilities, Current
SILEXION THERAPEUTICS CORP (SLXN) had Employee-related Liabilities, Current of $628.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current › Accrued Liabilities, Current
us-gaap:EmployeeRelatedLiabilitiesCurrent · last filed 2026-08-14
- 2026-06-30: Employee-related Liabilities, Current $628.00K.
- 2026-03-31: Employee-related Liabilities, Current $560.00K.
- 2025-12-31: Employee-related Liabilities, Current $879.00K.
- 2025-09-30: Employee-related Liabilities, Current $721.00K.
| Period end | Employee-related Liabilities, Current |
|---|---|
| 2026-06-30 | $628.00K 10-Q · filed 2026-08-14 |
| 2026-03-31 | $560.00K S-1/A · filed 2026-08-10 |
| 2025-12-31 | $879.00K 10-Q · filed 2026-08-14 |
| 2025-09-30 | $721.00K 10-Q · filed 2025-11-12 |
| 2025-06-30 | $628.00K 10-Q · filed 2025-08-12 |
| 2025-03-31 | $624.00K 10-Q · filed 2025-05-13 |
| 2024-12-31 | $642.00K S-1/A · filed 2026-08-10 |
| 2024-09-30 | $687.00K 10-Q · filed 2024-11-14 |
| 2024-06-30 | $251.00K 10-Q · filed 2024-08-29 |
| 2023-12-31 | $207.00K 8-K · filed 2025-08-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |